Author:
Wirth M.,Froschermaier S.,Manseck A.
Publisher
Springer Berlin Heidelberg
Reference51 articles.
1. Akakura K, Bruchovsky N, Goldenberg SL et al. (1993) Effects of intermittent androgen suppresion on androgen-dependent tumours. Apoptosis and serum prostate specific antigen. Cancer 71: 2782–2790.
2. Bangma CH, Hop WCJ, Schröder FH (1995) Serial prostate specific antigen measurements and progression in untreated confined (stages To to 3NXM0, grades 1 to 3) carcinoma of the prostate. J Urol 154:1403–1406.
3. Bangma CH, Kranse R, Blijenberg BG, Schröder FH (1997) The free-to-total serum prostate specific antigen ratio for staging prostate carcinoma. J Urol 157: 544–547.
4. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH (1992) The use of prostate specific antigen density to enhance the predicitive value of intermediate levels of serum prostate specific antigen. J Urol 147: 817–821.
5. Brawer MK, Aramburu EAG, Chen GL, Preston SD, Ellis WJ (1993) The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 150: 369–373.